The FDA approved linerixibat (Lynavoy) as the first drug indicated for cholestatic pruritus stemming from primary biliary ...
Learn why primary biliary cholangitis (PBC) causes intense itching, and explore treatment options, management tips, and ...
GSK (GSK) stock is in focus as the company wins FDA nod for Lynavoy, the first U.S. treatment for cholestatic pruritus in ...
London: The U.S. Food and Drug Administration approved GSK's drug for severe relentless itching caused by ‌a type ⁠of ⁠liver ...
Lynavoy is used to treat cholestatic pruritus, an extreme itch that affects almost 90% of patients with primary biliary ...
March ⁠19 (Reuters) - ⁠The U.S. ⁠Food and ​Drug ‌Administration approved ‌GSK's ⁠drug for ⁠severe relentless itching ​caused ...
GSK’s Lynavoy receives US FDA approval for cholestatic pruritus in patients with primary biliary cholangitis: London, UK Saturday, March 21, 2026, 11:00 Hrs [IST] GSK plc announ ...
The U.S. Food and Drug Administration has approved linerixibat, marking the first treatment specifically indicated for ...
Alfasigma’s buzzer-beater bet on GSK’s rare liver disease prospect has paid off. | Lynavoy is now the first FDA-approved ...
The British pharma giant will hand off its experimental itch treatment to Italian company Alfasigma as it focuses on broader ...
For the best experience, please enable JavaScript in your browser settings. UK: A tormented toddler's rare liver disease causes him to itch so much he deliberately ...
Cirrhosis can cause scar tissue to gradually replace healthy liver cells. In time, this can affect liver function and lead to hair, skin, and nail symptoms such as rashes and discoloration. Cirrhosis ...